Pionarus Bio, Inc.
1 known investors
Find your way into Pionarus Bio, Inc.
Sign up to see every warm intro you have to Pionarus Bio, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pionarus Bio, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.
Investors · 1
Frequently asked questions
- What does Pionarus Bio, Inc. do?
- Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.
- Who are Pionarus Bio, Inc.'s investors?
- Pionarus Bio, Inc.'s investors include Colorado BioScience Association.